Definition of Metabolic Syndrome

2004/01/26 by Scott M. Grundy, H. Bryan Brewer, H Bryan Brewer +3 · 38 citations
Medicine · #Diabetes, Cardiovascular Risks, and Lipoproteins #Natural Antidiabetic Agents Studies #Diet, Metabolism, and Disease

paper · doi:10.1161/01.cir.0000111245.75752.c6

Cited by

• Diagnosis and Management of the Metabolic Syndrome
• Defective FXR-SHP Regulation in Obesity Aberrantly Increases <i>miR-802</i> Expression, Promoting Insulin Resistance and Fatty Liver
• Adipose Tissue as an Endocrine Organ
• Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
• A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
• Food insecurity is associated with obesity and abdominal obesity among older adults: A cross-sectional analysis of ELSA study
• Query Cost Estimation in Relational Database Management System.
• Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
• Obesity-related non-communicable diseases: South Asians vs White Caucasians
• The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
• Electronic health record phenotyping improves detection and screening of\n type 2 diabetes in the general United States population: A cross-sectional,\n unselected, retrospective study
• Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy
• Metabolic psychiatry targeting metabolic dysregulation in mental health
• Cardiometabolic Syndrome: An Update on Available Mouse Models
• Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. [europepmc]
• Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. [europepmc]
• Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. [europepmc]
• Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. [europepmc]
• Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. [europepmc]
• Ethnic differences in hepatic steatosis: an insulin resistance paradox? [europepmc]
• Epidemiology of gout. [europepmc]
• Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? [europepmc]
• Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. [europepmc]
• Diabetes and hypertension: is there a common metabolic pathway? [europepmc]
• Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. [europepmc]
• Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. [europepmc]
• Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). [europepmc]
• Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. [europepmc]
• Age and cancer risk: a potentially modifiable relationship. [europepmc]
• Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. [europepmc]
• Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. [europepmc]
• Oxidative stress in obesity: a critical component in human diseases. [europepmc]
• Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). [europepmc]
• The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. [europepmc]
• The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. [europepmc]
• Metabolism disrupting chemicals and metabolic disorders. [europepmc]
• Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. [europepmc]
• Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation. [europepmc]
• Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. [europepmc]